To improve the patient experience and health equity, a team at Northwell Health’s Manhattan Eye, Ear & Throat Hospital (MEETH) has identified a way to reduce language as a barrier to care by improving language interpretation services.
The cumbersome interpretation process required clinicians to access landline phones locked behind the nurses’ station, move them to the pre-operative and post-operative patient stations, and ensure connectivity. Two-listener devices limited interaction to audio-only interpretation between the patient and a single caregiver.
MEETH learned that any language interpreting application could be quickly and inexpensively added to the hospital’s Equiva-based tablets. These devices had been deployed in 2020 and were primarily for in-room entertainment in the 30-bed unit where televisions were not available.
“Having LanguageLine on Equiva tablets has helped us improve patient experience and care,” said Kerry Donohue, MSN, RN, MEETH Patient Experience Manager and Culture Lead. “Our sisters are particularly excited. It is wonderful for members of the care team to be able to overcome language barriers and communication gaps. I cannot stress how important ease of use is in these situations.”
For its US Healthy People 2030 initiative, the US Department of Health and Human Services states that “trained interpreters and bilingual healthcare providers improve patient satisfaction, quality of care and health outcomes for people with limited English skills. Overall, healthcare organizations need to be more proactive in developing and implementing strategies to meet the language and literacy needs of diverse populations.”
The full customer success story is available on Equiva’s website.
SonALAsense, a pioneer in the development of SONALA-001 and Sonodynamic Therapy (SDT), a new drug-device combination designed to treat deadly cancers so patients can become survivors, has announced clinical, organizational and growth updates. It is the only company with SDT in clinical trials.
SonALAsense is working on two studies to evaluate the therapeutic potential of SONALA-001 SDT for DIPG and rGBM.
The primary objective of the phase 1/2 DIPG study is to evaluate the safety and tolerability of ALA SDT and to determine the maximum tolerated dose (MTD) or the recommended phase 2 dose (RP2D) of MR-guided focused ultrasound energy ( MRgFUS) in combination with SONALA-001 in patients with DIPG. This rare and deadly childhood brain tumor is aggressive and affects the pons, or brainstem, which controls many bodily functions.
The phase 2 study in rGBM builds on this positive proof-of-concept results from the first clinical phase 0/1 in humans study of SONALA-001 SDT in recurrent high-grade glioma (rHGG).
Three newly established individuals have joined SonALAsense Team of industry veterans. April Freeman has joined as Director of Patient Engagement and Advocacy along with distinguished physicians Margaret Dugan and Graeme Woodworth, who recently joined the Scientific Advisory Board.
The Company’s growth strategy continues to progress after raising $25 million from successful Series A and B funding rounds and an NCI-SBIR grant of approximately $2 million to fund the DIPG clinical trial.
behavioral health business Sensible care has closed a $13 million Series A funding round. Growth equity firm Volition Capital led the round with participation from Skyline Investors. Founded in 2017, the company provides on-network behavioral telehealth care to families and patients of all ages through licensed clinicians.
Sensible Care offers both psychiatric and therapeutic services and accepts most major insurance plans, including TRICARE, a healthcare program for US military personnel and their families.
“Our goal is not just to provide patients with access to mental health services on demand, but to do so with a level of quality that goes hand in hand with the long-term patient-provider relationships that are the bedrock of any traditional practice,” said Paul Kim, CEO of Sensible Care. “Having personally experienced the frustrating barriers to accessing quality mental health care, particularly for military veterans, my co-founders and I set out to create a solution that would maximize access for patients by making their insurance effective.” while providing value to providers through technology-enabled employment. ”
To read more click here.
A new report assessing the clinical robustness of digital health companies by broadening the definition of clinical rigor and examining companies’ public claims finds they still have work to do.
“Clinical robustness and public communication of claims remain low across much of the sector. These results underscore a significant opportunity for companies to differentiate themselves and for customers to demand greater validation of the products and services they purchase,” the report states.
To read the report published in Journal of Medical Internet Research, click here.
Picture: akindo, Getty Images